Data-driven hypothesis discovery from disease trajectories in multiple sclerosis.

Front Immunol · 2026 · PMC13120929 · PMID 42058203

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline non-significantp = 0.053so close (0.05 < p ≤ 0.1)

Comparison between patients who received fewer than two DMTs prior to CLAD initiation compared to those who received two or more: a significant difference in duration until CDW during the study (borderline non-significant, p = 0.053).

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.